Status:
COMPLETED
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Lead Sponsor:
Glaukos Corporation
Conditions:
Glaucoma, Open-Angle
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Phase III study to compare the safety and efficacy of intraocular implants containing Travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (Timolol) in reducing e...
Detailed Description
This is a prospective, randomized, double-masked, active-controlled, parallel-group, multi-center trial comparing the efficacy and safety of the Model G2TR-063 Travoprost Intraocular Implant and the M...
Eligibility Criteria
Inclusion
- Diagnosed with open-angle glaucoma or ocular hypertension
- C/D ratio ≤ 0.8
- Zero to two preoperative ocular hypotensive medications
Exclusion
- Active corneal inflammation or edema
- Retinal disorders not associated with glaucoma
Key Trial Info
Start Date :
September 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 19 2024
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT03868124
Start Date
September 17 2018
End Date
June 19 2024
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Sight
Las Vegas, Nevada, United States, 89145